Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ANGELINI, C.
Right arrow Articles by CANTARUTTI, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ANGELINI, C.
Right arrow Articles by CANTARUTTI, F.
NEUROLOGY 1976;26:633
© 1976 American Academy of Neurology

Carnitine deficiency of skeletal muscle

Report of a treated case

C. ANGELINI, M.D., S. LUCKE, M.S. and F. CANTARUTTI, M.D.

From the Department of Neurology, National Research Council Unit for Muscle Biology and Physiopathology, Institute of General Pathology, Department of Pediatrics, University of Padova, Italy.

We studied a 10-year-old girl with an insidious muscle disease beginning at age 7. Muscle biopsy showed that the majority of type I fibers were vacuolated and contained lipid excess. Carnitine deficiency was found in skeletal muscle. The patient was treated with 3.0 gm L-carnitine per day and with a medium-chain triglyceride diet. She showed a rapid improvement and recovery of strength. A muscle biopsy 8 months later showed a decreased lipid content. Oral carnitine replacement represents an effective treatment for the disease.

Requests for reprints should be addressed to Dr. Angelini, Department of Neurology, Via Giustiniani 6, University of Padova, Padova, Italy.

This study was supported by grants from the Muscular Dystrophy Associations of America.

This paper was presented in part at the twenty-seventh annual meeting of the American Academy of Neurology, Bal Harbour, Florida, May 1975.

Received for publication September 24, 1975.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
G. M. Andreozzi, A. Leone, R. Laudani, R. Martin, G. Deinit, and V. Cataldi
Levo-Propionyl-Carnitine Improves the Effectiveness of Supervised Physical Training on the Absolute Claudication Distance in Patients With Intermittent Claudication
Angiology, March 1, 2008; 59(1): 84 - 89.
[Abstract] [PDF]


Home page
J. Physiol.Home page
F. B. Stephens, D. Constantin-Teodosiu, and P. L. Greenhaff
New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle
J. Physiol., June 1, 2007; 581(2): 431 - 444.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
R. Pons and D. C. De Vivo
Primary and Secondary Carnitine Deficiency Syndromes
J Child Neurol, November 1, 1995; 10(2_suppl): 2S8 - 2S24.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.